These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22047792)

  • 21. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
    Ko WC; Shih CM; Lai YH; Chen JH; Huang HL
    Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diminished responsiveness to dobutamine as an inotrope in mice with cecal ligation and puncture-induced sepsis: attribution to phosphodiesterase 4 upregulation.
    Sakai M; Suzuki T; Tomita K; Yamashita S; Palikhe S; Hattori K; Yoshimura N; Matsuda N; Hattori Y
    Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1224-H1237. PubMed ID: 28455289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PDE4B5, a novel, super-short, brain-specific cAMP phosphodiesterase-4 variant whose isoform-specifying N-terminal region is identical to that of cAMP phosphodiesterase-4D6 (PDE4D6).
    Cheung YF; Kan Z; Garrett-Engele P; Gall I; Murdoch H; Baillie GS; Camargo LM; Johnson JM; Houslay MD; Castle JC
    J Pharmacol Exp Ther; 2007 Aug; 322(2):600-9. PubMed ID: 17519386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered expression of PDE1 and PDE4 cyclic nucleotide phosphodiesterase isoforms in 7-oxo-prostacyclin-preconditioned rat heart.
    Kostic MM; Erdogan S; Rena G; Borchert G; Hoch B; Bartel S; Scotland G; Huston E; Houslay MD; Krause EG
    J Mol Cell Cardiol; 1997 Nov; 29(11):3135-46. PubMed ID: 9405187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PDE4DIP in health and diseases.
    Mani A
    Cell Signal; 2022 Jun; 94():110322. PubMed ID: 35346821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phosphodiesterase inhibitors in airways disease.
    Fan Chung K
    Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases.
    Manns JM; Brenna KJ; Colman RW; Sheth SB
    Thromb Haemost; 2002 May; 87(5):873-9. PubMed ID: 12038792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PDE3 inhibition in dilated cardiomyopathy.
    Movsesian M; Wever-Pinzon O; Vandeput F
    Curr Opin Pharmacol; 2011 Dec; 11(6):707-13. PubMed ID: 21962613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profiling of functional phosphodiesterase in mesangial cells using a CRE-SEAP-based reporting system.
    Zhu Y; Yao J; Meng Y; Kasai A; Hiramatsu N; Hayakawa K; Miida T; Takeda M; Okada M; Kitamura M
    Br J Pharmacol; 2006 Jul; 148(6):833-44. PubMed ID: 16751794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting cyclic nucleotide phosphodiesterase in the heart: therapeutic implications.
    Miller CL; Yan C
    J Cardiovasc Transl Res; 2010 Oct; 3(5):507-15. PubMed ID: 20632220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overview of PDEs and their regulation.
    Omori K; Kotera J
    Circ Res; 2007 Feb; 100(3):309-27. PubMed ID: 17307970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The contribution of phosphodiesterases to cardiac dysfunction in rats with metabolic syndrome induced by a high-carbohydrate diet.
    Okatan EN; Turan B
    Can J Physiol Pharmacol; 2019 Nov; 97(11):1064-1072. PubMed ID: 31299169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac Phosphodiesterases and Their Modulation for Treating Heart Disease.
    Kim GE; Kass DA
    Handb Exp Pharmacol; 2017; 243():249-269. PubMed ID: 27787716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dexamethasone down-regulates cAMP-phosphodiesterase in human osteosarcoma cells.
    Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
    Biochem Pharmacol; 2005 Jan; 69(2):267-75. PubMed ID: 15627479
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natriuretic peptides increase beta1-adrenoceptor signalling in failing hearts through phosphodiesterase 3 inhibition.
    Qvigstad E; Moltzau LR; Aronsen JM; Nguyen CH; Hougen K; Sjaastad I; Levy FO; Skomedal T; Osnes JB
    Cardiovasc Res; 2010 Mar; 85(4):763-72. PubMed ID: 19900965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphodiesterase types 3 and 4 regulate the phasic contraction of neonatal rat bladder smooth myocytes via distinct mechanisms.
    Zhai K; Chang Y; Wei B; Liu Q; Leblais V; Fischmeister R; Ji G
    Cell Signal; 2014 May; 26(5):1001-10. PubMed ID: 24463006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effects of specific phosphodiesterase isoenzyme inhibitors on bovine oocyte meiotic maturation.
    Thomas RE; Armstrong DT; Gilchrist RB
    Dev Biol; 2002 Apr; 244(2):215-25. PubMed ID: 11944932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expression of cyclic nucleotide phosphodiesterases 4 in developing rat lung.
    Lopez E; Jarreau PH; Zana E; Franco-Montoya ML; Schmitz T; Evain-Brion D; Bourbon J; Delacourt C; Méhats C
    Dev Dyn; 2010 Sep; 239(9):2470-8. PubMed ID: 20652950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias.
    Lehnart SE; Wehrens XH; Reiken S; Warrier S; Belevych AE; Harvey RD; Richter W; Jin SL; Conti M; Marks AR
    Cell; 2005 Oct; 123(1):25-35. PubMed ID: 16213210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The induction of cyclic nucleotide phosphodiesterase 4 gene (PDE4D) impairs memory in a water maze task.
    Giorgi M; Modica A; Pompili A; Pacitti C; Gasbarri A
    Behav Brain Res; 2004 Sep; 154(1):99-106. PubMed ID: 15302115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.